Clinical Trial Update: Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using ciclosporin to manage steroid-resistant Type 1 reactions in leprosy, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• Ciclosporin (cyclosporine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Leprosy | Phase 2 | Status: COMPLETED